. 2017 Apr 14;23(14):2592–2600. doi: 10.3748/wjg.v23.i14.2592

Table 3.

Comparison of the five markers in the three groups

Patients characteristic	Control group	MAP group	SAP group
EPCs, %	0.55 ± 0.54	1.63 ± 1.47	6.61 ± 4.28^a ^b
TNF-α, pg/mL	19.16 ± 9.33^b	101.18 ± 74.59^a	208.16 ± 118.03^a ^b
WBC, 10⁹/L	6.45 ± 1.24^b	8.94 ± 2.58^a	10.90 ± 3.47^a
FIB, g/L	1.55 ± 0.79^b	4.47 ± 1.85^a	6.48 ± 2.23^a ^b
CRP, mg/dL	0.74 ± 0.40^b	2.70 ± 2.52^a	7.70 ± 3.36^a ^b

P < 0.05 vs Control;

P < 0.05 vs MAP. EPCs: SAP vs MAP, P = 0.00; SAP vs Control, P = 0.00; MAP vs Control, P = 0.54; TNF-α: SAP vs MAP, P = 0.00; SAP vs Control, P = 0.00; MAP vs Control, P = 0.01; FIB: SAP vs MAP, P = 0.00; SAP vs Control, P = 0.00; MAP vs Control, P = 0.00; WBC: SAP vs MAP, P = 0.07; SAP vs Control, P = 0.00; MAP vs Control, P = 0.02; CRP: SAP vs MAP, P = 0.00; SAP vs Control, P = 0.00; MAP vs Control, P = 0.04. CRP: C-reactive protein; EPCs: Endothelial progenitor cells; FIB: Fibrinogen; TNF-α: Tumor necrosis factor-alpha; WBC: White blood cells.